Is Entergy Mississippi, Inc. 1M BD 66 (EMP) a Buy, Sell, or Hold?
NYSE : EMP
Entergy Mississippi, Inc. 1M BD 66
$20.1 USD
$0.01 (0.02%)
- Volume
- 4.13K
- Average Volume
- 14.18K
- Market Capitalization
- $174.19M
- P/E Ratio
- 5.05
- Dividend Yield
- 6.10%
- Price Target
- Year High
- $21.21
- Year Low
- $19.89
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.68
| Source | Headline |
|---|---|
|
Poland's EMP teams up with Foxconn to build EV manufacturing hub
State-backed ElectroMobility Poland said Thursday it will partner with Taiwan's Foxconn to develop an electric vehicle production and research hub in southern Poland, advancing plans to create a domestic EV champion as Europe demand picks up. reuters.com - 2026-05-07 04:43:22 |
|
AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, durable and convenient mental health treatments, today announced expanded Phase 2a results for EMP-01 (oral R-MDMA) in adults with Social Anxiety Disorder (SAD) (n=70), demonstrating clinically meaningful and consistent improvements across clinician-rated symptoms, patient-reported experience, and real-world behavioral outcomes. At Day 43, EMP‑01 achieved a 38% reduction vs 15% on placebo (Hedges' g=0.84) on the patient-reported Social Phobia Inventory (SPIN), a 32% reduction vs 14% on placebo on the Subtle Avoidance Frequency Examination (SAFE), and a previously reported −11.9-point LS mean difference (LSMD) on the Liebowitz Social Anxiety Scale (LSAS) versus placebo (g=0.45), with 49% responder rates on both Clinical Global Impression-Improvement (CGI-I) (previously reported) and Patient Global Impressions of Change (PGI-C). EMP-01 was well tolerated, with no severe or serious adverse events. globenewswire.com - 2026-04-22 06:00:00 |
